Martin Buxton

Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma.

B. Liljas, C. Lamm, Romain A. Pauwels, 2003, The Journal of allergy and clinical immunology.

Patients' preferences for characteristics associated with treatments for osteoarthritis.

M. Buxton, R. Sheldon, J. Ratcliffe, 2003, Rheumatology.

Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra.

M. Sculpher, J. Brazier, A. Briggs, 2005, Health economics.

A Relative Cost‐effectiveness Analysis of Different Methods of Screening for Diabetic Retinopathy

D. Spiegelhalter, A. Kirby, M. Sculpher, 1991, Diabetic medicine : a journal of the British Diabetic Association.

Assessing low volume, high cost, potentially life saving surgical interventions: how and when? Left ventricular assist devices (LVADs) as a case study.

N. Caine, Martin Buxton, J. Wallwork, 1999, Journal of evaluation in clinical practice.

Cost effectiveness scenario analysis for a proposed trial of hormone replacement therapy.

J Townsend, M. Buxton, M Buxton, 1997, Health policy.

An economic evaluation of transdermal glyceryl trinitrate in the prevention of intravenous infusion failure.

B. O'brien, M. Buxton, H. Khawaja, 1990, Journal of clinical epidemiology.

ESTIMATING THE IMPACT OF A DIFFUSE TECHNOLOGY ON THE RUNNING COSTS OF A HOSPITAL

S Bryan, S. Bryan, M. Buxton, 2000, International Journal of Technology Assessment in Health Care.